Cargando…
Antibody Dependent Enhancement of SARS-CoV-2 Infection in the Era of Rapid Vaccine Development
BACKGROUND: Antibody dependent enhancement (ADE) is a unique immunopathological phenomenon in which pre-existing immunity to a viral agent accentuate disease severity upon secondary exposure. Multiple viruses have been shown to demsotrate ADE with no clear understanding of the underlying mechansims....
Autor principal: | Al Dossary, Reem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760241/ https://www.ncbi.nlm.nih.gov/pubmed/36545460 http://dx.doi.org/10.5455/medarh.2022.76.383-386 |
Ejemplares similares
-
Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018) -
Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination
por: Hasan, Amal, et al.
Publicado: (2021) -
SARS-CoV-2: vaccines in the pandemic era
por: Li, Dan-Dan, et al.
Publicado: (2021) -
Rapid biosensing SARS-CoV-2 antibodies in vaccinated healthy donors
por: Bian, Sumin, et al.
Publicado: (2022) -
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)